1. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
   Aswathy R. Devan et al, 2021, Pharmaceuticals CrossRef
2. Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance
   Łukasz Zadka et al, 2020, Cellular Oncology CrossRef
3. Examining the Mechanisms of Huachansu Injection on Liver Cancer through Integrated Bioinformatics Analysis
   Chao-yuan Huang et al, 2023, Recent Patents on Anti-Cancer Drug Discovery CrossRef
4. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
   Veera V. Shivaji R. Edupuganti et al, 2021, Recent Patents on Anti-Cancer Drug Discovery CrossRef
5. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
   Cristian Scheau et al, 2019, Analytical Cellular Pathology CrossRef
6. Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
   Jian Wang et al, 2021, Frontiers in Pharmacology CrossRef
7. A Case-control Study to Determine Metalloproteinase-12 and Lysyl Oxidase Levels in Iraqi women with Osteoporosis
   Layla O. Farhan et al, 2022, Research Journal of Pharmacy and Technology CrossRef
8. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma
   Dandan Lu et al, 2024, Aging CrossRef
9. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases
   Yigan Zhang et al, 2019, Current Drug Metabolism CrossRef